Expansion Opportunity CANTAB Pathway expands into professional healthcare and consumer wellness, creating opportunities to sell scalable cognitive assessment solutions to pharma sponsors, CROs, and healthcare providers seeking digital tools for screening, monitoring, and patient stratification across trials and real-world care.

Strategic Partnerships Recent collaborations with NIH and Monument Therapeutics position Cambridge Cognition as a trusted cognitive endpoint provider for CNS therapies. Leverage these relationships to pursue licensing, data analytics services, and platform integrations with trial data ecosystems in schizophrenia and other brain health indications.

Leadership Signals Growth Leadership changes signal growth and execution focus, opening conversations with finance and operations teams about licensing scale, implementation support, and total cost of ownership for cognitive assessment platforms.

Industry Engagement Active participation in industry summits and conferences provides direct access to trial designers and CNS researchers; target outreach for pilots, demonstrations, and co-funded studies to prove efficiency gains and improved patient stratification.

Tech and Integration A modern tech stack and analytics orientation suggests readiness for integration with EDC, trial management, and analytics platforms; opportunity to upsell data integration, advanced analytics, cloud hosting, and managed services to pharma and CRO customers.